Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2020-2026

  • receipt Report ID : 28286
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 101
  • list Pharmaceuticals and Healthcare

In 2020, the global Parkinson's Disease Therapeutics market size was million US$ and it is expected to reach million US$ by the end of 2026, with a CAGR of during 2020-2026.

This report focuses on the global Parkinson's Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Parkinson's Disease Therapeutics development in United States, Europe and China.

The key players covered in this study

GSK

Novartis

Boehringer Ingelheim

Teva Pharmaceutical

Abbvie

Merck

Akorn

Kyowa Hakko Kirin Pharma

Astellas Pharma

Desitin Arzneimittel

Endo Pharmaceuticals

F.Hoffmann-La Roche

H.Lundbeck

Valeant

Apokyn

Orion

Stada Arzneimittel

US WorldMeds

Valeant Pharmaceuticals

Market segment by Type, the product can be split into

Medications Therapeutics

Medical Devices Therapeutics

Market segment by Application, split into

Under 40 Years Old

40-65 Years Old

Above 65 Years Old

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Parkinson's Disease Therapeutics status, future forecast, growth opportunity, key market and key players.

To present the Parkinson's Disease Therapeutics development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Parkinson's Disease Therapeutics are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (2015-2026)

1.4.2 Medications Therapeutics

1.4.3 Medical Devices Therapeutics

1.5 Market by Application

1.5.1 Global Parkinson's Disease Therapeutics Market Share by Application (2015-2026)

1.5.2 Under 40 Years Old

1.5.3 40-65 Years Old

1.5.4 Above 65 Years Old

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Parkinson's Disease Therapeutics Market Size

2.2 Parkinson's Disease Therapeutics Growth Trends by Regions

2.2.1 Parkinson's Disease Therapeutics Market Size by Regions (2015-2026)

2.2.2 Parkinson's Disease Therapeutics Market Share by Regions (2015-2020)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Parkinson's Disease Therapeutics Market Size by Manufacturers

3.1.1 Global Parkinson's Disease Therapeutics Revenue by Manufacturers (2015-2020)

3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Manufacturers (2015-2020)

3.1.3 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)

3.2 Parkinson's Disease Therapeutics Key Players Head office and Area Served

3.3 Key Players Parkinson's Disease Therapeutics Product/Solution/Service

3.4 Date of Enter into Parkinson's Disease Therapeutics Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Parkinson's Disease Therapeutics Market Size by Type (2015-2020)

4.2 Global Parkinson's Disease Therapeutics Market Size by Application (2015-2020)

5 United States

5.1 United States Parkinson's Disease Therapeutics Market Size (2015-2020)

5.2 Parkinson's Disease Therapeutics Key Players in United States

5.3 United States Parkinson's Disease Therapeutics Market Size by Type

5.4 United States Parkinson's Disease Therapeutics Market Size by Application

6 Europe

6.1 Europe Parkinson's Disease Therapeutics Market Size (2015-2020)

6.2 Parkinson's Disease Therapeutics Key Players in Europe

6.3 Europe Parkinson's Disease Therapeutics Market Size by Type

6.4 Europe Parkinson's Disease Therapeutics Market Size by Application

7 China

7.1 China Parkinson's Disease Therapeutics Market Size (2015-2020)

7.2 Parkinson's Disease Therapeutics Key Players in China

7.3 China Parkinson's Disease Therapeutics Market Size by Type

7.4 China Parkinson's Disease Therapeutics Market Size by Application

8 Japan

8.1 Japan Parkinson's Disease Therapeutics Market Size (2015-2020)

8.2 Parkinson's Disease Therapeutics Key Players in Japan

8.3 Japan Parkinson's Disease Therapeutics Market Size by Type

8.4 Japan Parkinson's Disease Therapeutics Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Parkinson's Disease Therapeutics Market Size (2015-2020)

9.2 Parkinson's Disease Therapeutics Key Players in Southeast Asia

9.3 Southeast Asia Parkinson's Disease Therapeutics Market Size by Type

9.4 Southeast Asia Parkinson's Disease Therapeutics Market Size by Application

10 India

10.1 India Parkinson's Disease Therapeutics Market Size (2015-2020)

10.2 Parkinson's Disease Therapeutics Key Players in India

10.3 India Parkinson's Disease Therapeutics Market Size by Type

10.4 India Parkinson's Disease Therapeutics Market Size by Application

11 Central & South America

11.1 Central & South America Parkinson's Disease Therapeutics Market Size (2015-2020)

11.2 Parkinson's Disease Therapeutics Key Players in Central & South America

11.3 Central & South America Parkinson's Disease Therapeutics Market Size by Type

11.4 Central & South America Parkinson's Disease Therapeutics Market Size by Application

12 International Players Profiles

12.1 GSK

12.1.1 GSK Company Details

12.1.2 Company Description and Business Overview

12.1.3 Parkinson's Disease Therapeutics Introduction

12.1.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2015-2020)

12.1.5 GSK Recent Development

12.2 Novartis

12.2.1 Novartis Company Details

12.2.2 Company Description and Business Overview

12.2.3 Parkinson's Disease Therapeutics Introduction

12.2.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2015-2020)

12.2.5 Novartis Recent Development

12.3 Boehringer Ingelheim

12.3.1 Boehringer Ingelheim Company Details

12.3.2 Company Description and Business Overview

12.3.3 Parkinson's Disease Therapeutics Introduction

12.3.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2015-2020)

12.3.5 Boehringer Ingelheim Recent Development

12.4 Teva Pharmaceutical

12.4.1 Teva Pharmaceutical Company Details

12.4.2 Company Description and Business Overview

12.4.3 Parkinson's Disease Therapeutics Introduction

12.4.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2015-2020)

12.4.5 Teva Pharmaceutical Recent Development

12.5 Abbvie

12.5.1 Abbvie Company Details

12.5.2 Company Description and Business Overview

12.5.3 Parkinson's Disease Therapeutics Introduction

12.5.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2015-2020)

12.5.5 Abbvie Recent Development

12.6 Merck

12.6.1 Merck Company Details

12.6.2 Company Description and Business Overview

12.6.3 Parkinson's Disease Therapeutics Introduction

12.6.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2015-2020)

12.6.5 Merck Recent Development

12.7 Akorn

12.7.1 Akorn Company Details

12.7.2 Company Description and Business Overview

12.7.3 Parkinson's Disease Therapeutics Introduction

12.7.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2015-2020)

12.7.5 Akorn Recent Development

12.8 Kyowa Hakko Kirin Pharma

12.8.1 Kyowa Hakko Kirin Pharma Company Details

12.8.2 Company Description and Business Overview

12.8.3 Parkinson's Disease Therapeutics Introduction

12.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020)

12.8.5 Kyowa Hakko Kirin Pharma Recent Development

12.9 Astellas Pharma

12.9.1 Astellas Pharma Company Details

12.9.2 Company Description and Business Overview

12.9.3 Parkinson's Disease Therapeutics Introduction

12.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020)

12.9.5 Astellas Pharma Recent Development

12.10 Desitin Arzneimittel

12.10.1 Desitin Arzneimittel Company Details

12.10.2 Company Description and Business Overview

12.10.3 Parkinson's Disease Therapeutics Introduction

12.10.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020)

12.10.5 Desitin Arzneimittel Recent Development

12.11 Endo Pharmaceuticals

12.12 F.Hoffmann-La Roche

12.13 H.Lundbeck

12.14 Valeant

12.15 Apokyn

12.16 Orion

12.17 Stada Arzneimittel

12.18 US WorldMeds

12.19 Valeant Pharmaceuticals

13 Market Forecast 2020-2026

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2020-2026)

13.10 Market Size Forecast by Application (2020-2026)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Parkinson's Disease Therapeutics Key Market Segments

Table Key Players Parkinson's Disease Therapeutics Covered

Table Global Parkinson's Disease Therapeut